This is a trial to study how the molecular classification of breast cancer patients relate to their modes of presentation, biological behavior and treatment outcome.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Known cases of biopsy proven breast cancer in females.
- Registration Number
- CTRI/2018/04/012963
- Lead Sponsor
- Government funded Institution
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 286
Inclusion Criteria
Unilateral, biopsy proven invasive ductal carcinoma(IDC) breast with baseline normal hematological, renal and hepatic profile and baseline normal cardiac and pulmonary function status. Any T, any N, M0 stage.
Exclusion Criteria
Any evidence of distant metastasis at presentation, pregnant or lactating patients, previous history of any breast malignancy, presence of serious comorbidities or deranged hematological or biochemical parameters.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease Free Survival, Overall Survival.Timepoint: 3 years
- Secondary Outcome Measures
Name Time Method ocoregional Free Survival, Distant Metastasis Free SurvivalTimepoint: 3years